Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 428.25
-2.00 (-0.46%)
May 25, 2026, 11:21 AM IST
Biocon Market Cap
Biocon has a market cap or net worth of 696.3 billion as of May 22, 2026. Its market cap has increased by 73.21% in one year.
Market Cap
696.30B
Enterprise Value
837.71B
Revenue
169.27B
Ranking
n/a
PE Ratio
152.57
Stock Price
428.25
Market Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 696.30B, an increase of 1,433.27%. That is a compound annual growth rate of 13.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 696.30B | 32.47% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anthem Biosciences | 436.43B |
| OneSource Specialty Pharma | 210.31B |
| Concord Biotech | 120.65B |
| Blue Jet Healthcare | 76.51B |
| Supriya Lifescience | 62.30B |
| Zota Health Care | 40.28B |
| Dishman Carbogen Amcis | 30.63B |
| Panacea Biotec | 25.64B |